- Meeting abstract
- Open Access
Role of LDL level over hospital stay length of surgically treated coronary artery and obstructive peripheral arterial disease patients
https://doi.org/10.1186/1749-8090-10-S1-A228
© Çelik et al. 2015
- Published: 16 December 2015
Keywords
- Coronary Artery Disease
- Vascular Disease
- Disease Patient
- Important Risk Factor
- Peripheral Arterial Disease
Background/Introduction
Atherosclerosis is the most common and most important risk factor for cardiovascular diseases.
Aims/Objectives
Between dates January 2007 and December 2010, 868 coronary artery disease, and 268 peripheral vascular disease patients who were treated surgically at our clinic were investigated.
Method
Mean age of 868 coronary artery disease patients were 63,86 ± 11,17 (between 21-91 years) and 268 peripheral arterial disease patients were 65,44 ± 10,37 (between 21-92 years).
Results
Between 868 patients underwent surgery for coronary artery disease, LDL cholesterol level of 518 patients were >100 mg/dl and 350 patients were < 100 mg<7 mg/dl. Mean hospital stay length of patients was 6,8 days and 6,19 days, respectively. This difference was significant (p < 0.05).Between 268 patients underwent surgery for peripheral arterial disease, LDL cholesterol level of 177 patients were >100 mg/dl and 91 patients were < 100 mg<7 mg/dl. There was any significant correlation between LDL cholesterol levels and intensive care or hospital stay length (p > 0.05).
Discussion/Conclusion
We believe that, precise examination of preoperative risk factors and providing adequate pre and per operative medication will significantly reduce surgical morbidity rates, intensive care unit, and hospital stay lengths of coronary and peripheral arterial disease patients.
Consent
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Authors’ Affiliations
Copyright
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
